HealthEquity climbs as FY2026 HSA growth update and bullish price targets support
HealthEquity shares rose about 3% as investors continued to digest management’s Feb. 17 update showing FY2026 ended with 10.6M HSAs (+7% YoY) and $36.5B of HSA assets (+14% YoY). The move also tracks a bullish sell-side view after Deutsche Bank lifted its price target to $128 on March 20, 2026.
1) What’s moving HQY today
HealthEquity (HQY) is trading higher in a modest risk-on move, with investors leaning into the company’s recently disclosed fiscal-year-end operating momentum and a supportive analyst backdrop. The latest company update highlighted expanding HSA accounts and assets, plus management commentary that enterprise pipeline and retention remained strong heading into the new fiscal year. (ir.healthequity.com)
2) The key fundamental backdrop investors are buying
In its Feb. 17, 2026 update, HealthEquity said HSAs rose to 10.6 million as of Jan. 31, 2026 (+7% year over year), total accounts reached 17.8 million (+4%), and total HSA assets climbed to $36.5 billion (+14%). The company also disclosed an HSA cash maturity/ repricing schedule and reaffirmed outlook ranges at the time, framing the setup for potential margin and earnings leverage as cash yields reprice over time. (ir.healthequity.com)
3) Street support remains constructive
On the analyst side, recent price-target actions have kept sentiment constructive even as targets vary by firm. Deutsche Bank raised its price target to $128 while maintaining a Buy rating on March 20, 2026, reinforcing the bull case around HealthEquity’s growth profile and earnings power. (streetinsider.com)
4) What to watch next
Traders will focus on the next full earnings and guidance refresh, where HealthEquity has indicated it intends to provide updated full guidance for fiscal 2027 when reporting fiscal 2026 year-end results, alongside commentary on sales momentum and the yield outlook tied to cash repricing. Separately, investors may keep an eye on governance/insider-related disclosures such as pre-arranged 10b5-1 trading plans referenced in the company’s filings. (ir.healthequity.com)